Maternal care for other rhesus isoimmunization, first trimester (not applicable or unspecified)
ICD-10 O36.0910 is a billable code used to indicate a diagnosis of maternal care for other rhesus isoimmunization, first trimester (not applicable or unspecified).
Maternal care for rhesus isoimmunization refers to the management of pregnant women who have developed antibodies against Rh-positive blood due to previous sensitization. This condition can lead to hemolytic disease of the fetus and newborn (HDFN), which can cause fetal anemia, jaundice, and even fetal distress or growth restriction. In the first trimester, the focus is on monitoring the mother and fetus for any signs of complications. Care may include blood tests to assess Rh factor status, antibody screening, and ultrasound examinations to evaluate fetal growth and well-being. The management plan may also involve counseling regarding the risks of isoimmunization and potential interventions such as Rh immunoglobulin administration to prevent further sensitization. Early detection and appropriate maternal care are crucial to mitigate risks associated with this condition.
Detailed records of maternal blood type, antibody screening results, and any interventions performed.
Routine prenatal visits with Rh-negative mothers, management of isoimmunization during early pregnancy.
Ensure that all relevant laboratory results and treatment plans are documented to support coding.
Comprehensive documentation of high-risk assessments, including ultrasound findings and fetal monitoring.
Management of pregnancies complicated by Rh isoimmunization, including monitoring for fetal anemia.
Focus on interdisciplinary communication and documentation of all care provided.
Used during initial prenatal visits to determine Rh status.
Document the reason for testing and results.
Ensure that results are communicated to the patient and documented in the medical record.
Coding O36.0910 is crucial for identifying pregnancies at risk for complications due to rhesus isoimmunization, allowing for appropriate monitoring and intervention to ensure maternal and fetal health.
